Stock Price & Analysis

Based on the analysis of AptarGroup's (ATR) recent performance and projections, the stock presents a buying opportunity due to its oversold condition and positive earnings growth outlook. However, consider current market trends and your investment strategy before making a decision.

The price prediction for ATR stock in 2025 is expected to range between $140 and $150. This forecast is based on the company's recent earnings beat and revenue growth potential.

The S1 support level for ATR Stock is $144.76 ,The R1 resistant level for ATR Stock is $152.58.

As of the end of day on 2025-03-19, the price of ATR Stock was $145.61.

The target price for ATR Stock according to analyst rating is 180.50, with the highest price target at 205.00 and the lowest at 160.00. Analysts have a Strong Buy rating on ATR Stock overall.

The market cap of ATR is $9.7B.

Analysis and Insights

Valuation Metrics:

Aon plc (AON) is currently valued at a market cap of $87.1 billion, solidifying its position as a large-cap stock. The stock recently reached an all-time high of $412.97 on March 3, 2025, and is currently trading 2.4% below this peak. Over the past three months, AON has climbed 6.6%, outperforming the Nasdaq Composite, which fell 8.4% during the same period. Longer-term performance is also strong, with a 15.8% gain over six months and 27.3% over the past year, compared to the Nasdaq's 9% and 11.8%, respectively.

Financial Performance:

AON delivered strong Q4 results, with total revenue growing 23% year-over-year to $4.1 billion. Net income increased 45% to $734 million, and adjusted EPS rose 14% to $4.42, exceeding expectations. The stock is trading above its 200-day and 50-day moving averages, indicating an uptrend. Despite strong performance, AON dipped slightly after Q4 results, possibly due to market expectations or broader market conditions.

Market Trends and Sentiment:

The market is currently under stress, with the S&P 500 and Nasdaq facing pullbacks. The Fear & Greed Index is at extreme fear, which could be a contrarian buy signal. AON's resilience amid market stress suggests it's a quality stock. The overall market uncertainty, with policy concerns and economic friction, might impact valuations, but AON's fundamentals seem strong enough to justify its current price.

Conclusion:

Given AON's strong financials, outperformance, and positive analyst sentiment, it does not appear to be overvalued. The stock's current price near its mean target and slight dip after earnings suggest it is fairly valued. Therefore, ATR (AON) is not considered overvalued based on the provided data and analysis.

AptarGroup, Inc. is engaged in designing and manufacturing of drug and consumer product dosing, dispensing and protection technologies. The Company serves various end markets, including pharmaceutical, beauty, food, beverage, personal care and home care. The Company operates through three segments: Aptar Pharma, Aptar Beauty and Aptar Closures. Aptar Pharma segment supplies nasal drug delivery spray pumps and metered dose inhaler valves (MDIs) to the pharmaceutical and healthcare markets worldwide and supplies elastomer for injectable primary packaging components worldwide. The segment also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices. The Aptar Beauty segment sells a variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. Aptar Closures segment primarily sells dispensing closures.

The price prediction for ATR stock by 2030 is expected to range between $180 to $200 per share. This forecast is based on the company's strong earnings performance, with AptarGroup consistently beating EPS estimates and showing growth in its pharma and closures segments. The stock's current price of $145.03, combined with its solid financial position and industry outlook, supports this bullish projection.

ATR has a total of 13800 employees.